Leadership And Change: An Interview With Medicines Patent Pool Board Chair Marie-Paule Kieny 08/02/2018 Catherine Saez The unexpected announcement in December of the resignation of the Medicines Patent Pool executive director left the Pool searching for its new head. Marie-Paule Kieny, former World Health Organization assistant director general, now chair of the MPP governance board stepped in to oversee the MPP while the search goes on. She sat down recently for an interview with Intellectual Property Watch to explain that MPP is conducting business as usual, and is keeping firm in its plan to release the results of a feasibility study analysing the possibility for MPP to extend its licensing activities to other essential medicines still under patent. Continue reading -> WHO To Help Countries With Price Transparency, Regulation, TRIPS Flexibilities 08/02/2018 Catherine Saez World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) held a press conference yesterday to present progress made since his election last May. His office answered a follow-up question today from Intellectual Property Watch on access to medicines and how the organisation could help countries to do a better job. Continue reading -> WHO Director Presents The Press With Progress Report, Answers Tough Questions 07/02/2018 Catherine Saez Following a promise made at the beginning of his tenure to meet with the press regularly, World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) held a press conference today to paint a picture of what has been done under his leadership for the last seven months. He highlighted the establishment of the WHO General Programme of Work for 2019-2023, the quest for a new resource mobilisation strategy, measures taken on emergencies, and the push for universal health coverage. He also answered questions about the WHO nomination of President Mugabe that was cut short, and an appointment in his leadership team. Continue reading -> Leaked Letter Shows Pressure On Colombia Not To Issue Compulsory Licence For Glivec 06/02/2018 William New A newly leaked 2016 letter from the CEO of Novartis to the president of Colombia, made available by Swiss group Public Eye, shows the level of concern the Swiss pharmaceutical company had over the effect of possible issuance of a compulsory licence for Novartis drug Glivec in the pivotal South American economy. Continue reading -> Medicines Innovation And Access: Swiss Stimulate New Thinking 06/02/2018 Catherine Saez BERN, Switzerland -- What if reaching the United Nations Sustainable Development Goals on access to health for all depended on the willingness of all actors to see beyond outdated dichotomies? The concept may seem obvious, but is easier described than done. In an effort to break silos, the Swiss Federal Institute of Intellectual Property (IPI) brought together stakeholders of all sides last week to discuss how to harness political and economic will to achieve innovation leading to new medicines that are available and affordable for all in need. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO To Help Countries With Price Transparency, Regulation, TRIPS Flexibilities 08/02/2018 Catherine Saez World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) held a press conference yesterday to present progress made since his election last May. His office answered a follow-up question today from Intellectual Property Watch on access to medicines and how the organisation could help countries to do a better job. Continue reading -> WHO Director Presents The Press With Progress Report, Answers Tough Questions 07/02/2018 Catherine Saez Following a promise made at the beginning of his tenure to meet with the press regularly, World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) held a press conference today to paint a picture of what has been done under his leadership for the last seven months. He highlighted the establishment of the WHO General Programme of Work for 2019-2023, the quest for a new resource mobilisation strategy, measures taken on emergencies, and the push for universal health coverage. He also answered questions about the WHO nomination of President Mugabe that was cut short, and an appointment in his leadership team. Continue reading -> Leaked Letter Shows Pressure On Colombia Not To Issue Compulsory Licence For Glivec 06/02/2018 William New A newly leaked 2016 letter from the CEO of Novartis to the president of Colombia, made available by Swiss group Public Eye, shows the level of concern the Swiss pharmaceutical company had over the effect of possible issuance of a compulsory licence for Novartis drug Glivec in the pivotal South American economy. Continue reading -> Medicines Innovation And Access: Swiss Stimulate New Thinking 06/02/2018 Catherine Saez BERN, Switzerland -- What if reaching the United Nations Sustainable Development Goals on access to health for all depended on the willingness of all actors to see beyond outdated dichotomies? The concept may seem obvious, but is easier described than done. In an effort to break silos, the Swiss Federal Institute of Intellectual Property (IPI) brought together stakeholders of all sides last week to discuss how to harness political and economic will to achieve innovation leading to new medicines that are available and affordable for all in need. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Director Presents The Press With Progress Report, Answers Tough Questions 07/02/2018 Catherine Saez Following a promise made at the beginning of his tenure to meet with the press regularly, World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) held a press conference today to paint a picture of what has been done under his leadership for the last seven months. He highlighted the establishment of the WHO General Programme of Work for 2019-2023, the quest for a new resource mobilisation strategy, measures taken on emergencies, and the push for universal health coverage. He also answered questions about the WHO nomination of President Mugabe that was cut short, and an appointment in his leadership team. Continue reading -> Leaked Letter Shows Pressure On Colombia Not To Issue Compulsory Licence For Glivec 06/02/2018 William New A newly leaked 2016 letter from the CEO of Novartis to the president of Colombia, made available by Swiss group Public Eye, shows the level of concern the Swiss pharmaceutical company had over the effect of possible issuance of a compulsory licence for Novartis drug Glivec in the pivotal South American economy. Continue reading -> Medicines Innovation And Access: Swiss Stimulate New Thinking 06/02/2018 Catherine Saez BERN, Switzerland -- What if reaching the United Nations Sustainable Development Goals on access to health for all depended on the willingness of all actors to see beyond outdated dichotomies? The concept may seem obvious, but is easier described than done. In an effort to break silos, the Swiss Federal Institute of Intellectual Property (IPI) brought together stakeholders of all sides last week to discuss how to harness political and economic will to achieve innovation leading to new medicines that are available and affordable for all in need. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Leaked Letter Shows Pressure On Colombia Not To Issue Compulsory Licence For Glivec 06/02/2018 William New A newly leaked 2016 letter from the CEO of Novartis to the president of Colombia, made available by Swiss group Public Eye, shows the level of concern the Swiss pharmaceutical company had over the effect of possible issuance of a compulsory licence for Novartis drug Glivec in the pivotal South American economy. Continue reading -> Medicines Innovation And Access: Swiss Stimulate New Thinking 06/02/2018 Catherine Saez BERN, Switzerland -- What if reaching the United Nations Sustainable Development Goals on access to health for all depended on the willingness of all actors to see beyond outdated dichotomies? The concept may seem obvious, but is easier described than done. In an effort to break silos, the Swiss Federal Institute of Intellectual Property (IPI) brought together stakeholders of all sides last week to discuss how to harness political and economic will to achieve innovation leading to new medicines that are available and affordable for all in need. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines Innovation And Access: Swiss Stimulate New Thinking 06/02/2018 Catherine Saez BERN, Switzerland -- What if reaching the United Nations Sustainable Development Goals on access to health for all depended on the willingness of all actors to see beyond outdated dichotomies? The concept may seem obvious, but is easier described than done. In an effort to break silos, the Swiss Federal Institute of Intellectual Property (IPI) brought together stakeholders of all sides last week to discuss how to harness political and economic will to achieve innovation leading to new medicines that are available and affordable for all in need. Continue reading -> WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Executive Board Adopts Draft Resolution On TB, Stresses Importance Of Resistant TB In Overall Fight Against AMR 05/02/2018 Health Policy Watch Mirza Alas of the intergovernmental South Centre has published an analysis of the World Health Organization Executive Board approval of a draft resolution on actions toward ending tuberculosis and how it relates to antimicrobial resistance (AMR). The opening paragraphs and a link to the original are provided below. Continue reading -> “We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
“We Must Engage With Industry” – WHO Director Explains Limits On Lobbyists 31/01/2018 Catherine Saez The engagement of actors such as industry, civil society, philanthropy and academia with the World Health Organization has been a subject of controversy, with some of those actors being potentially able to influence the work of the organisation. A framework for engagement with those stakeholders was agreed two years ago. At last week's Executive Board meeting, the new WHO director general explained that engagement with those actors, and notably industry, is worth the risk, which he said can be managed. Continue reading -> The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Top 5 Issues In EU Medicines Policy For 2018 (Including IP) 30/01/2018 Guest contributor Yannis Natsis writes: There is a breakdown in communications between the pharmaceutical industry and Ministers of Health in Europe. The newly-deployed tactic of public, personalised attacks on national decision-makers who express concerns over high prices of medicines, reveal a change in the industry’s lobbying strategy that might damage the relationship irreparably. Continue reading -> WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval 29/01/2018 Catherine Saez The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board approved the programme last week and recommended its adoption at the upcoming World Health Assembly. The programme issued by the secretariat in autumn was revised twice, as countries requested amendments. Continue reading -> Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Importance Of Flu Pandemic Preparedness Confirmed By WHO Board Decision 26/01/2018 Catherine Saez One hundred years after the great Spanish flu pandemic, World Health Organization members today underlined their satisfaction with the organisation’s framework to get countries best prepared for the next pandemic: The WHO Executive Board agreed on keeping most of the funds coming to the framework for preparedness measures, and a smaller portion for response measures, unless emergency strikes. Continue reading -> Posts navigation Older Posts Newer Posts